---
title: Positive Data Reported for Monoclonal Antibody Treatment
description: Positive Data Reported for Monoclonal Antibody Treatment
---

[News ](https://www.yourway.com/news)

# [Positive Data Reported for Monoclonal Antibody Treatment](https://www.yourway.com/news/positive-data-reported-for-monoclonal-antibody-treatment)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | June 23, 2020

Humanigen has reported positive data from the [first clinical use of lenzilumab](https://www.clinicaltrialsarena.com/news/humanigen-lenzilumab-covid-19-patients/), which is a humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, in 12 COVID-19 patients. Those treated with the drug fully recovered in 5 days. Yourway has been working throughout the pandemic to transport clinical trial materials to patients that need it, despite challenges involving border closure and supply chain disruptions.

[View full post](https://www.yourway.com/news/positive-data-reported-for-monoclonal-antibody-treatment)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-06-23T09:00:00.397Z",
  "datePublished" : "2020-06-23T09:00:00Z",
  "headline" : "Positive Data Reported for Monoclonal Antibody Treatment",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1280,
    "url" : "https://f.hubspotusercontent30.net/hubfs/5402331/images/news_june/week4/iStock-991628182.jpg",
    "width" : 1920
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/positive-data-reported-for-monoclonal-antibody-treatment",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```